Joel Palefsky


Director, Anal Neoplasia Clinic, Research and Education (ANCRE) Center
Infectious disease physician
Clinician, researcher, and fan of good literature and bagels

About me

Dr. Joel Palefsky is an expert in infectious diseases and in cancers associated with these diseases. His expertise includes treating anal dysplasia, a precancerous condition that may lead to anal cancer and that is caused by the human papillomavirus (HPV).

Palefsky studies the biology of HPV and the Epstein-Barr virus, and is active in the development of new treatments.

Palefsky earned his medical degree at McGill University and completed a fellowship in infectious disease at Stanford University.

Palefsky is founder and president of the International Anal Neoplasia Society and president-elect of the International Papillomavirus Society.

  • Education

    McGill University, 1984

  • Residencies

    McGill University, Internal Medicine, 1984

  • Fellowships

    Stanford University, Infectious Disease, 1988

  • Board Certifications

    Infectious Disease, American Board of Internal Medicine/Infectious Disease

    Internal Medicine, American Board of Internal Medicine

  • Academic Title


  • Languages


A life helping others and contributing to our collective knowledge is a life well lived.

Anal Neoplasia Clinic, Research and Education (ANCRE) Center

1600 Divisadero St., Third Floor
San Francisco, CA 94115

My reviews


Overall Experience
66 Reviews
Dr Palefsky listens to his patients and explain science very clear and concise makes you feel relaxed
Explained things in a way that was easy to understand
66 Reviews
Did the doctor pay attention to your concerns
66 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
56 Reviews
Knew the important information about your medical history
66 Reviews
The provider showed respect for what you had to say
66 Reviews
The provider spent enough time with me
66 Reviews

Selected research

Decorative Caduceus

Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grad...

The log-rank test will be used to compare the treatment and control arms with respect to time to detection of anal cancer. For each arm, the hazard rate and its 95% confidence interval will be estimated. The proportional hazards m...